P
2.03
0.08 (4.10%)
| Previous Close | 1.95 |
| Open | 2.02 |
| Volume | 880,157 |
| Avg. Volume (3M) | 1,135,093 |
| Market Cap | 266,256,832 |
| Price / Sales | 66.00 |
| Price / Book | 1.42 |
| 52 Weeks Range |
| Operating Margin (TTM) | -2,025.74% |
| Diluted EPS (TTM) | -1.65 |
| Total Debt/Equity (MRQ) | 26.64% |
| Current Ratio (MRQ) | 5.58 |
| Operating Cash Flow (TTM) | -122.86 M |
| Levered Free Cash Flow (TTM) | -114.57 M |
| Return on Assets (TTM) | -51.51% |
| Return on Equity (TTM) | -136.87% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bearish | Bearish |
| Biotechnology (Global) | Bearish | Bearish | |
| Stock | Prime Medicine, Inc. | Bearish | Bearish |
AIStockmoo Score
0.5
| Analyst Consensus | 3.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | -0.5 |
| Average | 0.50 |
|
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| % Held by Insiders | 23.91% |
| % Held by Institutions | 59.05% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 12.00 (Chardan Capital, 491.13%) | Buy |
| Median | 10.00 (392.61%) | |
| Low | 1.50 (Citigroup, -26.11%) | Hold |
| Average | 7.90 (289.16%) | |
| Total | 4 Buy, 1 Hold | |
| Avg. Price @ Call | 1.59 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Citigroup | 27 May 2025 | 1.50 (-26.11%) | Hold | 1.23 |
| JMP Securities | 20 May 2025 | 6.00 (195.57%) | Buy | 1.18 |
| Chardan Capital | 19 May 2025 | 12.00 (491.13%) | Buy | 1.34 |
| 20 Mar 2025 | 16.00 (688.18%) | Buy | 2.01 | |
| HC Wainwright & Co. | 19 Mar 2025 | 10.00 (392.61%) | Buy | 2.00 |
| 03 Mar 2025 | 10.00 (392.61%) | Buy | 2.24 | |
| Citizens Capital Markets | 04 Mar 2025 | 10.00 (392.61%) | Buy | 2.21 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |